Kinnate Biopharma Inc. Contracts & Agreements
25 Contracts & Agreements
- Business Finance (4 contracts)
- Business Operations (1)
- Human Resources (15)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (2)
- Agreement and Plan of Merger, dated February 16, 2024, by and among XOMA Corporation, XRA 1 Corp. and Kinnate Biopharma Inc (Filed With SEC on February 16, 2024)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 15, 2023)
- Description of Securities (Filed With SEC on March 28, 2022)
- Change in Control and Severance Agreement between the Company and Neha Krishnamohan (Filed With SEC on June 7, 2021)
- Employment Letter between the Company and Neha Krishnamohan (Filed With SEC on June 7, 2021)
- Description of Securities (Filed With SEC on March 29, 2021)
- Amendment Number Three to Office Lease between the Registrant and Realty Income Properties 14, LLC, dated November 16, 2020 (Filed With SEC on November 30, 2020)
- Outside Director Compensation Policy (Filed With SEC on November 30, 2020)
- 2020 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on November 30, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on November 30, 2020)
- Specimen common stock certificate of the Registrant (Filed With SEC on November 30, 2020)
- Form of Underwriting Agreement (Filed With SEC on November 30, 2020)
- Office Lease between the Registrant and Realty Income Properties 14, LLC, dated May 2, 2018, as amended by Amendment Number One dated May 5, 2020 and Amendment Number Two dated... (Filed With SEC on November 13, 2020)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated August 24, 2020 (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Richard Williams, MBBS, Ph.D (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Eric Murphy, Ph.D (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Mark Meltz (Filed With SEC on November 13, 2020)
- Change in Control and Severance Agreement between the Registrant and Nima Farzan (Filed With SEC on November 13, 2020)
- Executive Incentive Compensation Plan (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Richard Williams, MBBS, Ph.D (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Eric Murphy, Ph.D (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Mark Meltz (Filed With SEC on November 13, 2020)
- Employment Letter between the Registrant and Nima Farzan (Filed With SEC on November 13, 2020)
- 2018 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 13, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on November 13, 2020)